24.12.2012 Views

Oral Abstract Session 01 - Global HIV Vaccine Enterprise

Oral Abstract Session 01 - Global HIV Vaccine Enterprise

Oral Abstract Session 01 - Global HIV Vaccine Enterprise

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Topic 3: B Cell Immunology and Antibody Functions<br />

P03.53 LB<br />

Study on the Functional Role of Immunoglobulin E as<br />

Surrogate Marker for <strong>HIV</strong>/AIDS Infection<br />

B. Sonaimuthu 1 , V. Baghyanathan 1<br />

1King Institute of Preventive Medicine & Research, Chennai,<br />

India<br />

Background: IgE class of antibodies has been found in mammals<br />

and plays an important role in allergic and hypersensitivity<br />

reactions. Certain viral infections are known to produce specific<br />

IgE antibodies, to the extent that significant changes in the level<br />

of total serum IgE may occur. Study attempts to associate the<br />

Level of Ig E in <strong>HIV</strong> progression.<br />

Methods: The study involves fifty <strong>HIV</strong> seropositive patients<br />

attending Anti-Retroviral Therapy Centre, Department of<br />

Sexually Transmitted Disease, Rajaji Government Hospital, and<br />

Madurai,India subjected for the present study. The individual<br />

involves 27 <strong>HIV</strong>/ AIDS Male patients, 23 <strong>HIV</strong>/ AIDS Female<br />

patients. The control sample comprises 15 <strong>HIV</strong> sero negatives.<br />

The samples were collected at the informed consent of the<br />

patients. Serum sample were collected and IgE was quantified<br />

using MAGIWELL IgE quantitative solid phase Enzyme- linked<br />

Immunosorbent assay (ELISA).<br />

Results: The study documents highest percentage of deviation<br />

from the control observed in Male <strong>HIV</strong> seropositives (43.7%) and<br />

age-wise influence documents highest percentage of deviation in<br />

the age group 15- 29 years (56%).<br />

Conclusion: Serum IgE level in the present study found to be<br />

elevated from the normal range documents the existence of<br />

imbalance between Th 1 and Th 2 and associated with T-cell<br />

dysfunction and a hypergammaglobulinemia. The present results<br />

suggest that elevation of circulating IgE levels may be due, at least<br />

in part, to specific IgE directed to the <strong>HIV</strong> virus rather than as a<br />

result of a nonspecific phenomenon. <strong>HIV</strong> infected adults indicate<br />

that total IgE is also increased during the early stages of disease,<br />

and this elevation appears to be independent of CD4 counts<br />

and is not correlated with the levels of other immunoglobulins,<br />

suggesting an important role for IgE as a surrogate marker of<br />

disease progression Further research need to be exploited to<br />

bring out the exact role of IgE in <strong>HIV</strong> pathogenesis.<br />

P03.54 LB<br />

AIDS <strong>Vaccine</strong> 2<strong>01</strong>2<br />

Posters<br />

Pre-existing Humoral Immunity In Military Smallpox<br />

<strong>Vaccine</strong>es Temporally Effects MVA-Vectored<br />

Transgene Expression in Dendritic Cells<br />

V. Ngauy 1 , B. Slike 2 , M. Marovich 2<br />

1 Armed Forces Research Institute of Medical Sciences,<br />

Bangkok, Thailand; 2 US Military <strong>HIV</strong> Research Program, MD,<br />

USA<br />

Background: Modified Vaccinia Ankara (MVA), a vector-based<br />

vaccine that targets dendritic cells (DC) and induces cellmediated<br />

immunity, is a promising <strong>HIV</strong> vaccine candidate. As<br />

MVA vaccination strategies continue to be explored, concerns<br />

arise regarding transferability to individuals with pre-existing<br />

immunity to vaccina, particularly military personnel. Prior<br />

reports suggest long-lasting vaccinia immunity after childhood<br />

vaccination. This study, conducted in a unique cohort of adult<br />

primary vaccinees, explores how pre-exisiting humoral immunity<br />

to vaccinia affects entry and transgene expression of MVAvectored<br />

vaccines in a primary human DC infection model.<br />

Methods: Serum from military personnel vaccinated against<br />

smallpox with either Dryvax or ACAM2000 vaccines were<br />

obtained at 4 time points post-vaccination (n=50 per time point,<br />

400 total). As a comparator, n=25 individuals with longitudinal<br />

sera available at corresponding time points were studied to<br />

compensate for inter-individual variability in response over time.<br />

Sera were tested for inhibition of infection of DCs in vitro using<br />

either MVA-GFP or MVA-CMDR, an <strong>HIV</strong> vaccine candidate with<br />

env/gag/pol inserts, currently in clinical trials. Vaccinia naïve<br />

sera served as a negative control. Vaccinia binding titers were<br />

measured by ELISA.<br />

Results: Vaccinia binding antibody titers waned after 5 years and<br />

were undetectable 10 years after vaccination. Neutralizing activity,<br />

as measured by transgene expression in DCs, confirmed this finding.<br />

Expression and neutralization of <strong>HIV</strong> p24 (gag) expression data in<br />

DC were equivalent to that of GFP. No differences in neutralization<br />

activity were detected between Dryvax and ACAM2000 vaccinee<br />

sera at corresponding time points.<br />

Conclusion: In an adult, military, primary vaccinee population,<br />

humoral responses to smallpox vaccination do not persist as<br />

long as reported in the civilian population vaccinated during<br />

childhood. This data suggests that pox-vector based vaccines<br />

may be used in the military population, and that the age of<br />

primary vaccination influences durability of humoral immunity.<br />

143<br />

POSTERS

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!